As returns on market increase, returns on owning Dr Reddys are expected to decrease at a much smaller rate. During bear market, Dr Reddys is likely to outperform the market.
MS BTech Vice-Chairman, Managing Director, COO, Member of The Management Council, Chairman of Management Committee and Member of Investment Committee
G Prasad Executive Vice Chairman of the Board, CEO
Anji Reddy Co-Founder, Executive Chairman and Member of the Scientific Advisory Board
MS Eng) Chairman, CEO, Member of the Management Council, Chairman of Investment Committee and Member of Management Committee
Dr Reddys Price and Market Media
The median price of Dr Reddys for the period between Thu, Apr 25, 2013 and Sat, May 25, 2013 is 37.43 with a coefficient of variation of 1.8. The daily time series for the period is distributed with a sample standard deviation of 0.67, arithmetic mean of 37.41, and mean deviation of 0.55. The Stock received some media coverage during the period.
Dr Reddys Laboratories Ltd [RDY] is traded on New York Stock Exchange in USA. It is located in Door No. , Road NoHyderabad, and employs 15,000 people. The company currently falls under 'Mid-Cap' category with total capitalization of 6.35 B. Dr Reddys Laboratories Ltd runs under Healthcare sector within Drug Manufacturers - Other industry. This company has 169.83 M outstanding shares of which 683.79 K shares are at this time shorted by investors with about 2.7 days to cover shorted positions.
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
-0.06% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
NYSE
